Ponatinib(Iclusig)

Ponatinib is a tyrosine kinase inhibitor that exerts its effect by selectively inhibiting the activities of BCR-ABL fusion protein and various other kinases.

15mg*30tablets
45mg*30tablets

WhatsApp

To ensure medication safety, consult customer service for free before purchasing. Returns/exchanges are not accepted except for quality issues.

Authentic

Guarantee

Fast Delivery

Privacy

Ponatinib Medication Guide

Important Precautions During Ponatinib Administration

Ponatinib is an oral medication mainly used for the treatment of specific types of chronic myeloid leukemia and acute lymphoblastic leukemia. It inhib···【Read More】
Update: 04 Mar,2026Source: Haiou HealthViews: 70
What Is Ponatinib Used For

Ponatinib is a third‑generation tyrosine kinase inhibitor (TKI) indicated for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromos···【Read More】
Update: 04 Mar,2026Source: Haiou HealthViews: 71